India’s regulatory framework for cosmetics is tightening, and the Maharashtra Food and Drug Administration is making its presence felt. In a series of enforcement actions targeting non-compliant beauty products, FDA officials have seized misbranded and allegedly unlicensed cosmetic products across multiple locations in Maharashtra, with a combined value exceeding Rs 34 lakh.
In Mumbai, FDA officials conducted inspections at cosmetic retailers and manufacturers, including a beauty store in Crawford Market and a manufacturing facility in Kandivali. The raids uncovered products carrying claims related to breast enhancement, fat burning, and skin improvement, none of which carried mandatory labelling information such as batch numbers, manufacturing licence details, or manufacturer identification. Authorities also found cosmetics being manufactured without the required licences. Products worth approximately Rs 5.16 lakh were seized across the Mumbai locations.
A separate enforcement operation in Karad resulted in the freezing of allegedly misbranded cosmetic stock valued at nearly Rs 29.5 lakh, significantly amplifying the scale of the crackdown. Legal action has been initiated under India’s Drugs and Cosmetics Act across all cases.
The enforcement action reflects a broader and intensifying regulatory focus on cosmetic products making misleading or unsubstantiated claims, as well as those failing to meet basic labelling and manufacturing compliance requirements. Authorities have flagged that such products pose genuine risks to consumers, as the absence of proper labelling makes it impossible to verify ingredients, manufacturing origins, or safety standards.
For India’s rapidly growing beauty services industry, the crackdown carries an important message. As the cosmetics market continues to expand rapidly, regulatory compliance is no longer peripheral, it is foundational. Salon professionals and beauty retailers who source products through unverified channels will face increasing exposure to legal and reputational risk.
The Maharashtra FDA action signals that enforcement of cosmetic regulations in India is becoming more structured, more frequent, and more consequential for those operating outside the compliance framework.
